BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial von Bockorny, Bruno, Semenisty, Valerya, Macarulla, Teresa, Borazanci, Erkut, Wolpin, Brian M., Stemmer, Salomon M., Golan, Talia, Geva, Ravit, Borad, Mitesh J., Pedersen, Katrina S., Park, Joon Oh, Ramirez, Robert A., Abad, David G., Feliu, Jaime, Muñoz, Andres, Ponz-Sarvise, Mariano, Peled, Amnon, Lustig, Tzipora M., Bohana-Kashtan, Osnat, Shaw, Stephen M., Sorani, Ella, Chaney, Marya, Kadosh, Shaul, Vainstein Haras, Abi, Von Hoff, Daniel D., Hidalgo, Manuel

Volltext

Abstract CT204: High cytotoxic T-cell or polymorphonuclear cell infiltrates in the tumor microenvironment correlate with responses to BL8040 plus pembrolizumab combination therapy... von Barreto, Carmelia M. Noia, Ledesma, Debora A., Gite, Swati, Solis, Luisa M., Jiang, Mei, Pandurengan, Renganayaki K., Wolff, Robert, Javle, Milind, Pant, Shubham, Varadhachary, Gauri, Shroff, Rachna, Vainstein-Haras, Abi, Sorani, Ella, Lustig, Tzipora M., Kashtan, Osnat, Gozlan, Yosi, Townson, Steven M., Fahey, Jeanne M., Yao, James, Wistuba, Ignacio I., Overman, Michael, Fogelman, David, Parra, Edwin R.

Volltext

A pilot study to assess the efficacy, safety, and pharmacodynamic effects of pembrolizumab and BL-8040 in patients with metastatic pancreatic cancer von Fogelman, David R., Townson, Steven Matthew, Varadhachary, Gauri R., Javle, Milind M., Shroff, Rachna T., Wolff, Robert A., Overman, Michael J., Ho, Linus, Vainstein Haras, Abi, Lustig, Tzipora M, Sorani, Ella, Lane, Maureen E., Kaufman, David Ross, Yao, James C.

Volltext

Evaluation of pharmacodynamic (PD) biomarkers in patients with metastatic pancreatic cancer treated with BL-8040, a novel CXCR4 antagonist von Hidalgo, Manuel M., Epelbaum, Ron, Semenisty, Valeriya, Geva, Ravit, Golan, Talia, Borazanci, Erkut Hasan, Stemmer, Salomon M., Borad, Mitesh J., Park, Joon Oh, Pedersen, Katrina, Wolpin, Brian M., Ramirez, Robert A., Becerra, Carlos, Shaw, Steven, Oberkovitz, Galia, Vainstein Haras, Abi, Sorani, Ella, Lustig, Tzipora M, Peled, Amnon, Von Hoff, Daniel D.

Volltext

Evaluation of pharmacodynamic (PD) biomarkers in patients with metastatic pancreatic cancer treated with BL-8040, a novel CXCR4 antagonist von Hidalgo, Manuel M., Epelbaum, Ron, Semenisty, Valeriya, Geva, Ravit, Golan, Talia, Borazanci, Erkut Hasan, Stemmer, Salomon M., Borad, Mitesh J., Park, Joon Oh, Pedersen, Katrina, Wolpin, Brian M., Ramirez, Robert A., Becerra, Carlos, Shaw, Stephen Michael, Oberkovitz, Galia, Sorani, Ella, Lustig, Tzipora M, Vainstein Haras, Abi, Peled, Amnon, Von Hoff, Daniel D.

Volltext